Novo Nordisk A/S (NVO)
NYSE·Healthcare·Drug Manufacturers - General
$43.41
+0.50%
Mkt Cap $176.82B
Analyst Ratings
No recent rating data.
Price Target (18 analysts)
$47.00
Range $47.00 – $47.00
Implied Upside
+8.3%
Consensus $47.00 vs current $43.41
NYSE·Healthcare·Drug Manufacturers - General
$43.41
+0.50%
Mkt Cap $176.82B
No recent rating data.
Price Target (18 analysts)
$47.00
Range $47.00 – $47.00
+8.3%
Consensus $47.00 vs current $43.41